Subscribe to our newsletter
Menu
CorEvitas is now enrolling qualified sites across the U.S. and Europe for the Adolescent Atopic Dermatitis Registry. If you are interested in participating, please get in touch using the link below.
Atopic dermatitis (AD), also known as atopic eczema, is a common skin condition that includes itchy red patches. It can be triggered by genetics and environmental factors, and includes the skin barrier, immune system, and skin bacteria. Signs and symptoms include redness, rash, pain, and itching, which can significantly impact quality of life. People with AD often have other conditions like asthma, food allergies, and hay fever. In the developed world, AD affects up to 10% of adults and 20% of children. The impact on children and adolescents may be more severe, leading to emotional distress, social isolation, and missed school. AD may also cause growth delays, bone issues, food allergies and sleep problems. Treatment options include topical creams and systemic medications. While new treatments are emerging, more long-term real-world data is needed, especially for adolescents.
The objective of the registry is to create a cohort of adolescents with atopic dermatitis to address a critical unmet need for real-world evidence and adolescent-specific developmental and safety data related to novel therapies for AD. Data collected will be used to better characterize the natural history of the disease and to extensively evaluate the effectiveness and safety of medications used for the treatment of AD to support ongoing risk-benefit evaluation by drug manufacturers and regulators.
Granular, longitudinal outcome measures will be collected during registry visits, including clinician-reported adolescent AD outcomes, lab measures and treatment history, and patient-reported outcomes assessing symptom impact and quality of life. Drug safety data also will be collected, including serious adverse events and other adverse events of special interest.
Read the Press Release, here.
Professor of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC
Professor of Dermatology, School of Medicine, Oregon Health & Science University, Portland, Oregon
